Hyperimmune activation is a strong predictor of disease progression during pathogenic immunodeficiency virus infections and is mediated in part by sustained type I IFN signaling in response to adventitious microbial infection. The immune inhibitory receptor programmed death–1 (PD-1) regulates functional exhaustion of virus-specific CD8+ T cells during chronic infections, and in vivo PD-1 blockade has been shown to improve viral control of SIV. Here, we show that PD-1 blockade during chronic SIV infection markedly reduced the expression of transcripts associated with type I IFN signaling in the blood and colorectal tissue of rhesus macaques (RMs). The effect of PD-1 blockade on type I IFN signaling was durable and persisted even under conditions of high viremia. Reduced type I IFN signaling was associated with enhanced expression of some of the junction-associated genes in colorectal tissue and with a profound decrease in plasma LPS levels, suggesting a possible repair of gut-associated junctions and decreased microbial translocation into the blood. PD-1 blockade enhanced immunity to gut-resident pathogenic bacteria, control of gut-associated opportunistic infections, and survival of SIV-infected RMs. Our results suggest PD-1 blockade as a potential novel therapeutic approach to enhance combination antiretroviral therapy by suppressing hyperimmune activation in HIV-infected individuals.
Ravi Dyavar Shetty, Vijayakumar Velu, Kehmia Titanji, Steven E. Bosinger, Gordon J. Freeman, Guido Silvestri, Rama Rao Amara
Title and authors | Publication | Year |
---|---|---|
Interleukin-21 and anti-α4β7 dual therapy during ART promotes immunological and microbiome responses in SIV-infected macaques
Samuel D. Johnson, Maria Pino, Arpan Acharya, Julien A. Clain, Deepanwita Bose, Kevin Nguyen, Justin Harper, Francois Villinger, Mirko Paiardini, Siddappa Byrareddy |
JCI Insight | 2025 |
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection
Webb GM, Pessoa CT, McCullen AJ, Hwang JM, Humkey MC, Thormin-Odum R, Kukula KA, Smedley J, Fischer M, Sciurba J, Bochart RM, Shriver-Munsch C, Ndhlovu LC, Sacha JB |
Journal of virology | 2024 |
Immune checkpoint inhibitors in infectious disease
King HA, Lewin SR |
Immunological Reviews | 2024 |
PD-1 blockade following ART interruption enhances control of pathogenic SIV
in rhesus macaques
Vijayakumar Velu, Kehmia Titanji, Hasan Ahmad, Ravi D Shetty, Lakshmi Chennareddi, Gordon Freeman, Rafi Ahmed, Rama Amara |
Proceedings of the National Academy of Sciences | 2022 |
Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities
A Timofeeva, S Sedykh, G Nevinsky |
Human vaccines | 2022 |
Expression Profile and Biological Role of Immune Checkpoints in Disease Progression of HIV/SIV Infection
Y Sun, J Xue |
Viruses | 2022 |
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury
Gunasekaran M, Mishra R, Saha P, Morales D, Cheng WC, Jayaraman AR, Hoffman JR, Davidson L, Chen L, Shah AM, Bittle G, Fu X, Tulshyan A, Abdullah M, Kingsbury T, Civin C, Yang P, Davis ME, Bolli R, Hare JM, Sharma S, Kaushal S |
iScience | 2022 |
Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
Brunet-Ratnasingham E, Morou A, Dubé M, Niessl J, Baxter AE, Tastet O, Brassard N, Ortega-Delgado G, Charlebois R, Freeman GJ, Tremblay C, Routy JP, Kaufmann DE |
EBioMedicine | 2022 |
Cellular Senescence in Immunity against Infections
Marrella V, Facoetti A, Cassani B |
International journal of molecular sciences | 2022 |
Impact of Anti–PD-1 and Anti–CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study
TA Rasmussen, L Rajdev, A Rhodes, A Dantanarayana, S Tennakoon, S Chea, T Spelman, S Lensing, R Rutishauser, S Bakkour, M Busch, JD Siliciano, RF Siliciano, MH Einstein, DP Dittmer, E Chiao, SG Deeks, C Durand, SR Lewin |
Clinical Infectious Diseases | 2021 |
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
AB López, MA Penedo, T Rivera-Baltanas, D Pérez-Rodríguez, D Alonso-Crespo, C Fernández-Pereira, JM Olivares, RC Agís-Balboa |
Biomedicines | 2021 |
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
SD Johnson, OA Olwenyi, N Bhyravbhatla, M Thurman, K Pandey, EA Klug, M Johnston, SR Dyavar, A Acharya, AT Podany, CV Fletcher, M Mohan, K Singh, SN Byrareddy |
World journal of gastroenterology : WJG | 2021 |
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8 + T cells in lymphoid tissue
SA Rahman, B Yagnik, AP Bally, KN Morrow, S Wang, TH Vanderford, GJ Freeman, R Ahmed, RR Amara |
Science Immunology | 2021 |
Critical Role of Zinc Transporter (ZIP8) in Myeloid Innate Immune Cell Function and the Host Response against Bacterial Pneumonia
SC Hall, DR Smith, SR Dyavar, TA Wyatt, DR Samuelson, KL Bailey, DL Knoell |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
SR Dyavar, R Singh, R Emani, GP Pawar, VD Chaudhari, AT Podany, SN Avedissian, CV Fletcher, DB Salunke |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
J Li, HH Huang, B Tu, MJ Zhou, W Hu, YL Fu, XY Li, T Yang, JW Song, X Fan, YM Jiao, RN Xu, JY Zhang, CB Zhou, JH Yuan, C Zhen, M Shi, FS Wang, C Zhang |
Frontiers in immunology | 2021 |
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4+ T-cell activation/ exhaustion
OA Olwenyi, B Asingura, P Naluyima, GU Anywar, J Nalunga, M Nakabuye, M Semwogerere, B Bagaya, F Cham, A Tindikahwa, F Kiweewa, EZ Lichter, AT Podany, CV Fletcher, SN Byrareddy, H Kibuuka |
2021 | |
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques
KD Kauffman, S Sakai, NE Lora, S Namasivayam, PJ Baker, O Kamenyeva, TW Foreman, CE Nelson, D Oliveira-de-Souza, CL Vinhaes, Z Yaniv, CS Arleham, A Sette, GJ Freeman, R Moore, A Sher, KD Mayer-Barber, BB Andrade, J Kabat, LE Via, DL Barber |
Science Immunology | 2021 |
Mathematical modeling of N-803 treatment in SIV-infected non-human primates
JW Cody, AL Ellis-Connell, SL OConnor, E Pienaar, RM Ribeiro |
PLoS computational biology | 2021 |
Disease Progression in Children With Perinatal Human Immunodeficiency Virus Correlates With Increased PD-1+ CD8 T Cells That Coexpress Multiple Immune Checkpoints
Tailor J, Foldi J, Generoso M, McCarty B, Alankar A, Kilberg M, Mwamzuka M, Marshed F, Ahmed A, Liu M, Borkowsky W, Unutmaz D, Khaitan A |
The Journal of Infectious Diseases | 2021 |
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics
S Wang, Q Zhang, H Hui, K Agrawal, MA Karris, TM Rana |
Emerging Microbes & Infections | 2020 |
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
J Harper, S Gordon, CN Chan, H Wang, E Lindemuth, C Galardi, SD Falcinelli, SL Raines, JL Read, K Nguyen, CS McGary, M Nekorchuk, K Busman-Sahay, J Schawalder, C King, M Pino, L Micci, B Cervasi, S Jean, A Sanderson, B Johns, AA Koblansky, H Amrine-Madsen, J Lifson, DM Margolis, G Silvestri, KJ Bar, D Favre, JD Estes, M Paiardini |
Nature Medicine | 2020 |
The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination
N Seddiki, F Picard, L Dupaty, Y Lévy, V Godot |
Human vaccines | 2020 |
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
S Vigano, S Bobisse, G Coukos, M Perreau, A Harari |
Frontiers in immunology | 2020 |
Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates
BJ Rust, LS Kean, L Colonna, KE Brandenstein, NH Poole, W Obenza, MR Enstrom, CR Maldini, GI Ellis, CM Fennessey, ML Huang, BF Keele, KR Jerome, JL Riley, HP Kiem, CW Peterson |
Blood | 2020 |
The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
H Chen, M Moussa, M Catalfamo |
Frontiers in immunology | 2020 |
Combination rhIL-15 and Anti-PD-L1 (Avelumab) Enhances HIVGag-Specific CD8 T-Cell Function
BA Goshu, H Chen, M Moussa, J Cheng, M Catalfamo |
The Journal of Infectious Diseases | 2020 |
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy:
BJ Macatangay, RT Gandhi, RB Jones, DK Mcmahon, CM Lalama, RJ Bosch, JC Cyktor, AS Thomas, L Borowski, SA Riddler, E Hogg, E Stevenson, JJ Eron, JW Mellors, CR Rinaldo |
AIDS | 2020 |
Transcriptomic approach predicts a major role for transforming growth factor beta type 1 pathway in L‐Dopa ‐induced dyskinesia in parkinsonian rats
SR Dyavar, LF Potts, G Beck, BL Shetty, B Lawson, AT Podany, CV Fletcher, RR Amara, SM Papa |
Genes, brain, and behavior | 2020 |
Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
S Takahama, T Yamamoto |
Frontiers in Cellular and Infection Microbiology | 2020 |
Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8+ T-Cells During Chronic SIV Infection of Rhesus Macaques
G Enyindah-Asonye, A Nwankwo, MA Rahman, R Hunegnaw, C Hogge, SH Hait, EJ Ko, T Hoang, M Robert-Guroff |
Frontiers in immunology | 2020 |
Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
SR Dyavar, TM Mykris, LC Winchester, KK Scarsi, CV Fletcher, AT Podany |
Scientific Reports | 2020 |
Functional MAIT Cells Are Associated With Reduced Simian–Human Immunodeficiency Virus Infection
A Murugesan, C Ibegbu, TM Styles, AT Jones, U Shanmugasundaram, PB Reddy, SJ Rahman, P Saha, M Vijay-Kumar, EM Shankar, RR Amara, V Velu |
Frontiers in immunology | 2020 |
Investigational drugs with dual activity against HBV and HIV (Review)
S Sun, Q Yang, Y Sheng, Y Fu, C Sun, C Deng |
Experimental and therapeutic medicine | 2020 |
Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
G Mylvaganam, AG Yanez, M Maus, BD Walker |
Frontiers in immunology | 2019 |
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
F Perdomo-Celis, NA Taborda, MT Rugeles |
Frontiers in immunology | 2019 |
rhIL-15 and anti-PD-L1 combination therapy expands a CXCR3+PD1-/low CD8 T cell subset in SIV-infected rhesus macaques
P Chen, H Chen, M Moussa, J Cheng, T Li, J Qin, JD Lifson, MC Sneller, L Krymskaya, S Godin, HC Lane, M Catalfamo |
The Journal of Infectious Diseases | 2019 |
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
Y Wang, YR Chung, S Eitzinger, N Palacio, S Gregory, M Bhattacharyya, P Penaloza-MacMaster, CM Walker |
PLoS pathogens | 2019 |
Between a shock and a hard place: challenges and developments in HIV latency reversal
JM Zerbato, HV Purves, SR Lewin, TA Rasmussen |
Current Opinion in Virology | 2019 |
Combination Anti-PD-1 and Anti-Retroviral Therapy Provides Therapeutic Benefit Against SIV
Geetha Mylvaganam, Lynette Chea, Gregory Tharp, Sakeenah Hicks, Vijayakumar Velu, Smita Iyer, Claire Deleage, Jacob Estes, Steven E. Bosinger, Gordon Freeman, Rafi Ahmed, Rama Rao Amara |
JCI Insight | 2018 |
Inhibition of p38 MAPK in combination with ART reduces SIV-induced immune activation and provides additional protection from immune system deterioration
O Chaudhary, V Narayan, F Lelis, B Linz, M Watkins, R Veazey, A Aldovini, SR Ross |
PLoS pathogens | 2018 |
T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses
A Saeidi, K Zandi, YY Cheok, H Saeidi, WF Wong, CY Lee, HC Cheong, YK Yong, M Larsson, EM Shankar |
Frontiers in immunology | 2018 |
Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
M Sperk, R Domselaar, U Neogi |
International journal of molecular sciences | 2018 |
The Roles of Coinhibitory Receptors in Pathogenesis of Human Retroviral Infections
K Yasuma-Mitobe, M Matsuoka |
Frontiers in immunology | 2018 |
Nanotechnology approaches to eradicating HIV reservoirs
S Cao, KA Woodrow |
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2018 |
Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assay
SR Dyavar, Z Ye, SN Byrareddy, KK Scarsi, LC Winchester, JA Weinhold, CV Fletcher, AT Podany |
Scientific Reports | 2018 |
T cell exhaustion: from pathophysiological basics to tumor immunotherapy
K Catakovic, E Klieser, D Neureiter, R Geisberger |
Cell Communication and Signaling | 2017 |
Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming
J Chan, PY Kim, E Kranz, Y Nagaoka, YJ Lee, J Wen, HJ Elsaesser, M Qin, DG Brooks, GE Ringpis, IS Chen, M Kamata |
AIDS Research and Human Retroviruses | 2017 |
The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation
Y Dou, HC Yim, CD Kirkwood, BR Williams, AJ Sadler |
The EMBO Journal | 2017 |
CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway
P Penaloza-MacMaster |
Immunology | 2017 |
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
CL Gay, RJ Bosch, J Ritz, JM Hataye, E Aga, RL Tressler, SW Mason, CK Hwang, DM Grasela, N Ray, JC Cyktor, JM Coffin, EP Acosta, RA Koup, JW Mellors, JJ Eron |
The Journal of Infectious Diseases | 2017 |
HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions
J Foldi, L Kozhaya, B McCarty, M Mwamzuka, F Marshed, T Ilmet, M Kilberg, A Kravietz, A Ahmed, W Borkowsky, D Unutmaz, A Khaitan |
The Journal of Infectious Diseases | 2017 |
Immune checkpoint blockade in infectious diseases
MN Wykes, SR Lewin |
Nature Reviews Immunology | 2017 |
Anti-Bovine Programmed Death-1 Rat–Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle
T Okagawa, S Konnai, A Nishimori, N Maekawa, R Ikebuchi, S Goto, C Nakajima, J Kohara, S Ogasawara, Y Kato, Y Suzuki, S Murata, K Ohashi |
Frontiers in immunology | 2017 |
HIV-specific CD8+ T cells and HIV eradication
Brad Jones, Bruce Walker |
Journal of Clinical Investigation | 2016 |
Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
R Ponte, V Mehraj, P Ghali, A Couëdel-Courteille, R Cheynier, JP Routy |
EBioMedicine | 2016 |
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti–programed death-ligand 1 (Avelumab)
AL Gill, SA Green, S Abdullah, CL Saout, S Pittaluga, H Chen, R Turnier, J Lifson, S Godin, J Qin, MC Sneller, JM Cuillerot, H Sabzevari, HC Lane, M Catalfamo |
AIDS | 2016 |
Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239
LT Zhang, RR Tian, HY Zheng, GQ Pan, XY Tuo, HJ Xia, XS Xia, W Pang, YT Zheng |
Immunology | 2016 |
Type I interferons in viral control and immune regulation
JR Teijaro |
Current Opinion in Virology | 2016 |
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
J R Teijaro |
Advances in immunology | 2016 |
Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease
J Attanasio, EJ Wherry |
Immunity | 2016 |
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
V Vieillard, S Gharakhanian, O Lucar, C Katlama, O Launay, B Autran, RH Fang, J Crouzet, RL Murphy, P Debré |
Oncotarget | 2016 |
Microbial translocation and microbiome dysbiosis in HIV-associated immune activation:
AS Zevin, L McKinnon, A Burgener, NR Klatt |
Current Opinion in HIV and AIDS | 2016 |
The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells
M Mühle, T Kroniger, K Hoffmann, J Denner |
Immunologic Research | 2016 |
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
GM Chew, T Fujita, GM Webb, BJ Burwitz, HL Wu, JS Reed, KB Hammond, KL Clayton, N Ishii, M Abdel-Mohsen, T Liegler, BI Mitchell, FM Hecht, M Ostrowski, CM Shikuma, SG Hansen, M Maurer, AJ Korman, SG Deeks, JB Sacha, LC Ndhlovu, G Silvestri |
PLoS pathogens | 2016 |
Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques
ER Roberts, DG Carnathan, H Li, GM Shaw, G Silvestri, MR Betts, DT Evans |
PLoS pathogens | 2016 |
CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells
P Penaloza-MacMaster, NM Provine, E Blass, DH Barouch |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia
C Peligero, J Argilaguet, R Güerri-Fernandez, B Torres, C Ligero, P Colomer, M Plana, H Knobel, F García, A Meyerhans, G Silvestri |
PLoS pathogens | 2015 |
Role of PD-1 co-inhibitory pathway in HIV infection and potential therapeutic options
V Velu, RD Shetty, M Larsson, EM Shankar |
Retrovirology | 2015 |
Lipopolysaccharide Increases Immune Activation and Alters T Cell Homeostasis in SHIV B’WHU Chronically Infected Chinese Rhesus Macaque
GH Zhang, RD Wu, HY Zheng, XL Zhang, MX Zhang, RR Tian, GM Liu, W Pang, YT Zheng |
Journal of Immunology Research | 2015 |
Next-Generation mRNA Sequencing Reveals Pyroptosis-Induced CD4 + T Cell Death in Early Simian Immunodeficiency Virus-Infected Lymphoid Tissues
W Lu, AJ Demers, F Ma, G Kang, Z Yuan, Y Wan, Y Li, J Xu, M Lewis, Q Li, G Silvestri |
Journal of virology | 2015 |
Lack of the programmed death-1 receptor renders host susceptible to enteric microbial infection through impairing the production of the mucosal natural killer cell effector molecules
S Solaymani-Mohammadi, O Lakhdari, I Minev, S Shenouda, BF Frey, R Billeskov, SM Singer, JA Berzofsky, L Eckmann, MF Kagnoff |
Journal of leukocyte biology | 2015 |
Dysregulation of multiple inflammatory molecules in lymph node and ileum of macaques during RT-SHIV infection with or without antiretroviral therapy
Z Ambrose, C Kline, P Polacino, SL Hu |
Journal of Medical Primatology | 2014 |
HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
A Battistini, M Sgarbanti |
Viruses | 2014 |
Dendritic cells in progression and pathology of HIV infection
O Manches, D Frleta, N Bhardwaj |
Trends in Immunology | 2014 |
Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection
H Cho, M Kikuchi, Y Li, N Nakamoto, VK Amorosa, ME Valiga, KM Chang |
Frontiers in immunology | 2014 |
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
A Saez-Cirion, B Jacquelin, F Barre-Sinoussi, M Muller-Trutwin |
Philosophical Transactions of the Royal Society B: Biological Sciences | 2014 |
Tissue-Expressed B7-H1 Critically Controls Intestinal Inflammation
L Scandiuzzi, K Ghosh, KA Hofmeyer, YM Abadi, E Lázár-Molnár, EY Lin, Q Liu, H Jeon, SC Almo, L Chen, SG Nathenson, X Zang |
Cell Reports | 2014 |
Multiple Low-Dose Challenges in a Rhesus Macaque AIDS Vaccine Trial Result in an Evolving Host Response That Affects Protective Outcome
C Selinger, N Strbo, L Gonzalez, L Aicher, JM Weiss, GL Law, RE Palermo, M Vaccari, G Franchini, ER Podack, MG Katze |
Clinical and vaccine immunology : CVI | 2014 |
Expansion of Dysfunctional Tim-3-Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
T Fujita, BJ Burwitz, GM Chew, JS Reed, R Pathak, E Seger, KL Clayton, JM Rini, MA Ostrowski, N Ishii, MJ Kuroda, SG Hansen, JB Sacha, LC Ndhlovu |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Diminished Viral Control during Simian Immunodeficiency Virus Infection Is Associated with Aberrant PD-1hi CD4 T Cell Enrichment in the Lymphoid Follicles of the Rectal Mucosa
GH Mylvaganam, V Velu, JJ Hong, S Sadagopal, S Kwa, R Basu, B Lawson, F Villinger, RR Amara |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway
NL Bowers, ES Helton, RP Huijbregts, PA Goepfert, SL Heath, Z Hel |
PLoS pathogens | 2014 |
Animal models for viral infection and cell exhaustion:
CS McGary, G Silvestri, M Paiardini |
Current Opinion in HIV and AIDS | 2014 |
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease:
LR Cockerham, V Jain, E Sinclair, DV Glidden, W Hartogenesis, H Hatano, PW Hunt, JN Martin, CD Pilcher, R Sekaly, JM McCune, FM Hecht, SG Deeks |
AIDS | 2014 |
Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function
A Gibson, M Ogese, A Sullivan, E Wang, K Saide, P Whitaker, D Peckham, L Faulkner, BK Park, DJ Naisbitt |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
HIV-1 Tat Protein Induces PD-L1 (B7-H1) Expression on Dendritic Cells through Tumor Necrosis Factor Alpha- and Toll-Like Receptor 4-Mediated Mechanisms
R Planes, L BenMohamed, K Leghmari, P Delobel, J Izopet, E Bahraoui |
Journal of virology | 2014 |
STAT3, STAT4, NFATc1, and CTCF Regulate PD-1 through Multiple Novel Regulatory Regions in Murine T Cells
JW Austin, P Lu, P Majumder, R Ahmed, JM Boss |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients
Z Zhang, J Fu, X Xu, S Wang, R Xu, M Zhao, W Nie, X Wang, J Zhang, T Li, L Su, FS Wang |
AIDS | 2013 |
Immune Activation and Collateral Damage in AIDS Pathogenesis
F Miedema, MD Hazenberg, K Tesselaar, D Baarle, RJ de Boer, JA Borghans |
Frontiers in immunology | 2013 |
Immune activation and HIV persistence: implications for curative approaches to HIV infection
NR Klatt, N Chomont, DC Douek, SG Deeks |
Immunological Reviews | 2013 |
Dendritic cell dysregulation during HIV-1 infection
E Miller, N Bhardwaj |
Immunological Reviews | 2013 |
Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1
A Boasso |
Scientifica | 2013 |
Combined approaches for HIV cure
DM Margolis, DJ Hazuda |
Current Opinion in HIV and AIDS | 2013 |
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
MJ Fuller, B Callendret, B Zhu, GJ Freeman, DL Hasselschwert, W Satterfield, AH Sharpe, LB Dustin, CM Rice, A Grakoui, R Ahmed, CM Walker |
Proceedings of the National Academy of Sciences | 2013 |
Strength of PD-1 signaling differentially affects T-cell effector functions
F Wei, S Zhong, Z Ma, H Kong, A Medvec, R Ahmed, GJ Freeman, M Krogsgaard, JL Riley |
Proceedings of the National Academy of Sciences | 2013 |
PD-1 coinhibitory signals: The link between pathogenesis and protection
DA Kulpa, M Lawani, A Cooper, Y Peretz, J Ahlers, RP Sékaly |
Seminars in Immunology | 2013 |
Microbial translocation, immune activation, and HIV disease
NR Klatt, NT Funderburg, JM Brenchley |
Trends in Microbiology | 2013 |
An Altered Maturation and Adhesion Phenotype of Dendritic Cells in Diseased Individuals Compared to Asymptomatic Carriers of Human T Cell Leukemia Virus Type 1
SL Manuel, M Sehgal, ZK Khan, JJ Goedert, MR Betts, P Jain |
AIDS Research and Human Retroviruses | 2013 |
Programmed Death 1 Lives Up to Its Reputation in Active Tuberculosis
SB Sable |
The Journal of Infectious Diseases | 2013 |
T-cell reconstitution during murine acquired immunodeficiency syndrome (MAIDS) produces neuroinflammation and mortality in animals harboring opportunistic viral brain infection
MB Mutnal, SJ Schachtele, S Hu, JR Lokensgard |
Journal of Neuroinflammation | 2013 |
Re-evaluation of PD-1 expression by T cells as a marker for immune exhaustion during SIV infection
JJ Hong, PK Amancha, K Rogers, AA Ansari, F Villinger |
PloS one | 2013 |
Induction of SerpinB2 and Th1/Th2 modulation by SerpinB2 during lentiviral infections in vivo
LD Major, TS Partridge, J Gardner, SJ Kent, R Rose, A Suhrbier, WA Schroder |
PloS one | 2013 |
In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit
PK Amancha, JJ Hong, K Rogers, AA Ansari, F Villinger |
Journal of immunology (Baltimore, Md. : 1950) | 2013 |
Expansion or Depletion of T Follicular Helper cells During HIV Infection: Consequences for B cell Responses
Onabajo OO, Mattapallil JJ |
Current HIV research | 2013 |
Attacking the HIV Reservoir from the Immune and Viral Perspective
M Massanella, J Martinez-Picado, J Blanco |
Current HIV/AIDS Reports | 2012 |
Can immunotherapy be useful as a "functional cure" for infection with Human Immunodeficiency Virus-1?
G Vanham, EV Gulck |
Retrovirology | 2012 |
Nonhuman Primate Models for HIV Cure Research
C Apetrei, I Pandrea, JW Mellors |
PLoS pathogens | 2012 |
Enhancing immune responses to limit chronic immune activation during SIV
JD Estes |
Journal of Clinical Investigation | 2012 |